Welcome to BioReagent Hub Hotline:19920083827
本站自营/精选产品 www.yeasen.com  |  价格与库存以本站实时信息为准
本站精选 · 品质自营查看原始页面 ›
Vendor Tel:400-6111-883
Product data sheet PD-40191ES
Ceturegel® Matrix for Organoid culture,Phenol Red-Free,LDEV-Free 基质胶 Ceturegel® Matrix for Organoid culture,Phenol Red-Free,LDEV-Free 基质胶
Enquiry

Tell us your volume and application; we reply with a quote.

Start enquiry

Ceturegel® Matrix for Organoid culture,Phenol Red-Free,LDEV-Free 基质胶

Scan for product
类器官培养类器官研究肿瘤研究细胞生物学研究
Product no.40191ES Sizes2 options SourceYeasen · Official
Cat. No. 40191ES08
现货 ¥1,688.00 促¥2,405.00
Qty 1
Enquire now
Enquire / bulk Compare

Specifications & Enquiry

Tick the specs you need to submit them together; or enquire one by one. Cat. numbers are carried into the RFQ.

Cat.No Spec Price Status
40191ES08 5 mL ¥1,688.00促¥2,405.00 现货 Enquire
40191ES10 10 mL ¥3,038.00促¥4,335.00 现货 Enquire
Submit enquiry Price is on application; bulk sizes can be sampled on request.

Overview

Specifications

Brand翌圣生物 Yeasen
Cat.No40191ES
Specification1、无污染:通过严格透析除菌,保证无细菌和真菌生长2、蛋白浓度:浓度8~20 mg/ml3、内毒素残留:含量<8EU/ml4、安全性高:不含LDEV残留5、产量高:单月批产量在50L级别以上6、支原体残留:检测验证无支原体污染
Origin翌圣生物科技(上海)股份有限公司
技术平台 类器官培养
应用方法 类器官研究构建胰腺癌、宫颈癌、小鼠小肠等类器官模型 肿瘤研究用于肿瘤细胞类器官培养及肿瘤研究 细胞生物学研究用于细胞形态、迁移、侵袭和基因表达研究
适用物种种属 小鼠
生物特性参数 来源EHS小鼠肿瘤 主要成分层粘连蛋白、Ⅳ型胶原、硫酸乙酰肝素蛋白聚糖(HSPG)和巢蛋白等 生长因子TGF-beta、EGF、IGF、FGF、组织纤溶酶原激活物等 细胞产品子类基质胶 应用类器官培养、细胞培养
技术参数 蛋白浓度8~20 mg/ml 无菌性无细菌和真菌生长 支原体检测无支原体污染 内毒素残留<8 EU/ml LDEV残留不含LDEV残留 储存条件-20℃保存,有效期两年 运输条件干冰运输 产品形式液体 批产量单月批产量在50L级别以上
实验类型 类器官培养支持类器官构建与生长 三维细胞培养模拟体内基底膜环境进行细胞培养

FAQ

Q:可以做那些类器官

A:常见癌种的类器官均可以使用Yeasen类器官专用基质胶进行培养


Documents & Citations

Published citations

[1] Bian, Y., Shan, G., Bi, G., et al. (2025). Targeting polyamine metabolism and ferroptosis enhances the efficacy of KRAS-targeted therapy depending on KEAP1 status. Nature Communications, *16*, 9923. doi: 10.1038/s41467-025-65441-4 (IF:15.7)

[2] Bi, G., Liang, J., Bian, Y., et al. (2025). Targeting ALDH16A1 mediated thioredoxin lysosomal degradation to enhance ferroptosis susceptibility in SMARCA4-deficient NSCLC. Nature Communications, *16*, 8181. doi: 10.1038/s41467-025-63687-6 (IF:15.7)

[3] Shan, G., Bian, Y., Ren, S., et al. (2025). Sarcosine sensitizes lung adenocarcinoma to chemotherapy by dual activation of ferroptosis via PDK4/PDHA1 signaling and NMDAR-mediated iron export. Experimental Hematology & Oncology, *14*, 60. doi: 10.1186/s40164-025-00657-0 (IF:13.5)

Recommended reading

Related products

✉Email 💬Message 👤Member
↑Top